Adds Private Equity and Operational Experience to Help Scale iOrganBio’s Operations CHAPEL HILL, N.C. — iOrganBio, an innovator in intelligent cell manufacturing redefining how human cells are engineered and reliably produced at scale for research and therapy, including as New Approach Methodologies (NAMs) in alignment with FDA direction, today announced the appointment of Karol Jarzabek […]
Waters Corporation’s Q4 2025 Financial Results Conference Call will now be held on Monday, February 9th, 2026 at 8:30am ET in conjunction with the expected close of the transaction MILFORD, Mass. — Waters Corporation (NYSE: WAT) (the “Company” or “Waters”) today announced that, at the Company’s Special Meeting of Shareholders (the “Special Meeting”) held today, Waters […]
Expansion of iXCells’ iPSCore platform with integration of 3D human organoid expertise will enable evaluation of drug toxicity and tissue-specific responses Responds to growing demand for scalable, patient-relevant human models to support translational decision-making in drug development San Diego, CA: iXCells Biotechnologies (“iXCells”), a leading provider of human cell-based solutions and custom iPSC services, and Rosebud […]
Solna, Sweden – Epigenica AB announces the launch of its EpiFinder™ Analysis Service, a fully managed, high-throughput platform designed to make advanced epigenomic research faster, more accessible and highly reproducible. The EpiFinder™ Analysis Service provides comprehensive, end-to-end support by managing every step of the workflow, from study design and sample logistics to sequencing, data processing, and […]
Life sciences executive brings 20-plus years’ experience in biopharma and diagnostics, with precision oncology expertise STOCKHOLM — Pixelgen Technologies today announced the appointment of life sciences executive Nis Glavind Kruse as the company’s Chief Commercial Officer. Kruse will lead Pixelgen’s global commercial organization as the company accelerates adoption of its Pixelgen Proxiome Kit and new technologies enabling advanced protein interactomics research […]
Foster City, Calif. — Signios Bio today announced the launch of a new grant program supporting innovative spatial transcriptomics research using the 10x Genomics Xenium 5K Spatial Transcriptomics platform. The program is designed to enable U.S.-based researchers to generate high-plex, single-cell-resolution spatial gene expression data in human and mouse tissues. The Signios Bio Xenium 5K Spatial […]
A major technological advance in DNA writing enables researchers to construct and create in the language of biology The Genyro Team Genyro, a biotechnology company advancing next-generation DNA construction was co-founded by: (From Left to Right) Noah Robinson, Professor Kaihang Wang (Chief Scientific Advisor), Dr. Adrian Woolfson (President, and CEO), and Professor Brian Hie. Photo […]
SAN DIEGO, Calif. — BioTuring and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a strategic collaboration to streamline and accelerate the path from data generation to biological insight for single cell and spatial research workflows. The collaboration connects 10x’s Chromium single cell platform and Xenium and Visium […]
VENLO, Netherlands — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Mark Stevenson has been appointed as an independent member of the Supervisory Board as of January 23, 2026, and will stand for election at the next Annual General Meeting in June 2026. In addition, Prof. Dr. Ross Levine has stepped down from […]
Newest version of BD® Research Cloud features an AI-powered tool for automated panel design to improve quality, efficiency and usability of scientific results across research areas FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of BD® Research Cloud 7.0, furthering the company’s AI roadmap […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
